Status:
COMPLETED
Bronchoscopic Endotracheal Intubation Through a SAD - Physician Performance
Lead Sponsor:
Nordsjaellands Hospital
Conditions:
Airway Morbidity
Eligibility:
All Genders
Brief Summary
Prospective observational study with the primary objective is to assess technical competence in anaesthesiology specialists who perform bronchoscopic endotracheal intubation through a supraglottic air...
Detailed Description
This study is a preplanned prospective observational substudy of a randomised controlled trial (RCT) with the primary aim to compare time to intubation when using two different supraglottic airway dev...
Eligibility Criteria
Inclusion
- Anaesthetist specialists performing bronchoskopic tracheal intubation through a supraglottic airway device
- The supraglottic airway device is either i-gelTM or a Ambu® AuraGainTM (4 in total, 2 of each i random order).
Exclusion
- Refuse to participate
- Any other involvement in the research project
Key Trial Info
Start Date :
January 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04743440
Start Date
January 18 2021
End Date
August 20 2022
Last Update
October 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nordsjaellands hospital Hilleroed
Hillerød, Denmark, 3400